BRPI0510855A - medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis - Google Patents

medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis

Info

Publication number
BRPI0510855A
BRPI0510855A BRPI0510855-1A BRPI0510855A BRPI0510855A BR PI0510855 A BRPI0510855 A BR PI0510855A BR PI0510855 A BRPI0510855 A BR PI0510855A BR PI0510855 A BRPI0510855 A BR PI0510855A
Authority
BR
Brazil
Prior art keywords
estriol
pharmaceutically acceptable
oral administration
esters
medicament
Prior art date
Application number
BRPI0510855-1A
Other languages
English (en)
Inventor
Joachim Moormann
Walter Elger
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of BRPI0510855A publication Critical patent/BRPI0510855A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MEDICAMENTO EM FORMA DE PELìCULA PARA MINISTRAçãO ORAL E USO DE ESTRIOL E/OU DE éSTERES DE ESTRIOL FARMACEUTICAMENTE ACEITáVEIS. A presente invenção refere-se a medicamentos com um formato de uma película os quais são ministrados oralmente, particularmente de uma forma bucal, e os quais são intencionados para o tratamento de perturbações de saúde climatéricas, os referidos medicamentos contendo estriol e/ou pelo menos um éster de estriol farmacologicamente aceitável, tanto só ou em combinação com pelo menos um gestágeno.
BRPI0510855-1A 2004-05-14 2005-05-06 medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis BRPI0510855A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004023984A DE102004023984A1 (de) 2004-05-14 2004-05-14 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
PCT/EP2005/004894 WO2005110358A2 (de) 2004-05-14 2005-05-06 Filmförmiges, oral zu verabreichendes arzneimittel, enthaltend estriol

Publications (1)

Publication Number Publication Date
BRPI0510855A true BRPI0510855A (pt) 2007-12-26

Family

ID=34977101

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510855-1A BRPI0510855A (pt) 2004-05-14 2005-05-06 medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis

Country Status (16)

Country Link
US (1) US20070243217A1 (pt)
EP (1) EP1761242A2 (pt)
JP (1) JP2007537178A (pt)
KR (1) KR20070040753A (pt)
CN (1) CN1997349A (pt)
AR (1) AR048958A1 (pt)
AU (1) AU2005244409A1 (pt)
BR (1) BRPI0510855A (pt)
CA (1) CA2566325A1 (pt)
DE (1) DE102004023984A1 (pt)
IL (1) IL179014A0 (pt)
MX (1) MXPA06012890A (pt)
NO (1) NO20065657L (pt)
RU (1) RU2006140649A (pt)
TW (1) TW200536547A (pt)
WO (1) WO2005110358A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2252261A2 (en) * 2008-02-13 2010-11-24 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
BRPI0908477A2 (pt) * 2008-02-13 2018-03-27 Bayer Schering Pharma Ag sistema de distribuição de medicamento contendo estradiol
KR20110020782A (ko) * 2008-04-24 2011-03-03 이브스트라, 인코포레이티드 장용 폴리머 중에 분산된 프로게스토겐 및 에스트로겐을 포함하는 경구 피임약 제형
US20110250274A1 (en) * 2008-09-19 2011-10-13 Shaked Ze Ev Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
KR102044515B1 (ko) * 2019-08-20 2019-11-14 이영환 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3888269T2 (de) * 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
DE59309063D1 (de) * 1992-03-21 1998-11-19 Entec Verwendung von östriol zur herstellung einen transdermalen therapeutischen systeme zur behandlung von klimakterischer osteoporose
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
KR100913910B1 (ko) * 2000-01-18 2009-08-26 바이엘 쉐링 파마 악티엔게젤샤프트 호르몬 보충 요법용 드로스피렌온

Also Published As

Publication number Publication date
KR20070040753A (ko) 2007-04-17
WO2005110358A2 (de) 2005-11-24
NO20065657L (no) 2006-12-07
CN1997349A (zh) 2007-07-11
JP2007537178A (ja) 2007-12-20
RU2006140649A (ru) 2008-05-27
AU2005244409A1 (en) 2005-11-24
MXPA06012890A (es) 2007-07-19
WO2005110358A3 (de) 2007-03-15
DE102004023984A1 (de) 2005-12-08
TW200536547A (en) 2005-11-16
CA2566325A1 (en) 2005-11-24
EP1761242A2 (de) 2007-03-14
IL179014A0 (en) 2007-03-08
US20070243217A1 (en) 2007-10-18
AR048958A1 (es) 2006-06-14

Similar Documents

Publication Publication Date Title
JP2010525050A5 (pt)
BRPI0518622A2 (pt) usos de antagonistas de receptor do tipo 1 de interleucina-1(il-1r1) para a fabricaÇço de um medicamento para o tratamento de uma doenÇa respiratària; composiÇço farmacÊutica que compreende um antagonista do il-1r1 e um veÍculo fisiologicamente aceitÁvel e dispositivo de liberaÇço de medicamento
BRPI0716439B8 (pt) sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
EP1909772A4 (en) TRANSDERMAL DRUG FORMULATION
JP2010503695A5 (pt)
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
ATE440598T1 (de) Analgesische zusammensetzung von topisch angewendeten, nichtsteroiden und entzündungshemmenden arzneimitteln und opioiden
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
WO2006063189A3 (en) Multi-layered chewing gum tablet with quick disintegration layer
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
BRPI0519171A2 (pt) dispositivo de administraÇço de medicamento oftÁlmico
ATE426635T1 (de) Arzneimittelverabreichung
NO20073403L (no) Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1
WO2008109385A3 (en) Oral administration of a calcitonin
TW200603787A (en) Topical preparations containing ambroxol
WO2007123848A3 (en) Therapeutic compositions containing modified class i slrp proteins
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
JP2007119497A5 (pt)
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
MA31227B1 (fr) Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
WO2005030132A3 (en) Therapeutic regimens for administering drug combinations

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]